Health Trials

Ground-glass Opacity

3

Review clinical trials related to Ground-glass Opacity. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Cryoablation vs Thoracoscopic Surgery for GGN

The aim of this study is to investigate the efficacy and safety of Cryoablation and Thoracoscopic Surgery in the treatment of pulmonary ground-glass nodules.

Participants needed: 160
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai Chest HospitalUpdated: Mar 20, 2026Locations: 1
Eligibility criteria

Patients ≥ 18 years old. [+6]

Patients in poor general condition, with ECOG physical fitness score >2, unable... [+11]

Read more
Status: Not yet recruiting

Percutaneous Robotic Navigation Microwave Ablation Versus CT-guided Microwave Ablation in the Treatment of Pulmonary Nodules With Ground-glass Opacity

1. To compare the precision of robot-guided microwave ablation and CT-guided microwave ablation in the treatment of ground-glass nodules. 2. To evaluate the safety of robot-assisted microwave ablation and CT-guided microwave ablation in the treatment of ground-glass nodules. 3. Explore the application potential of robot navigation microwave ablation technology in the treatment of pulmonary nodules.

Participants needed: 116
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: Fujian Medical University Union HospitalUpdated: Feb 5, 2026
Eligibility criteria

Aged 18 to 85 years [+5]

Smoking cessation duration <2 weeks [+10]

Read more
Status: Not yet recruiting

Wedge Resection for Ground-glass Opacity-featured Lung Cancer (ECTOP-1020)

This is a clinical trial from the Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1020. The goal of this clinical trial is to confirm the therapeutic effect of Wedge resection for ground-glass opacity-featured lung cancer with a size less than 2cm and a consolidation-to-tumor ratio between 0.25 to 0.5.

Participants needed: 286
Trial details
Phase: Phase 3Age: 18-80Biological sex: AllType: InterventionalSponsor: Fudan UniversityUpdated: Oct 26, 2023Locations: 1
Eligibility criteria

Patients who sign the informed consent form and are willing to complete the stud... [+10]

Postoperative pathologic diagnosis of adenocarcinoma in situ or minimally invasi... [+5]

Read more